Invion Limited (ASX:IVX)
Australia · Delayed Price · Currency is AUD 0.0920
0.00 (0.00%)
Jan 28, 2026, 3:59 PM AEST
Invion Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
7.88M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | - | - | - |
| Jun 30, 2024 | 3.69M | -410.46K | -10.00% |
| Jun 30, 2023 | 4.10M | 812.95K | 24.70% |
| Jun 30, 2022 | 3.29M | 961.74K | 41.28% |
| Jun 30, 2021 | 2.33M | -1.15M | -32.98% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vitura Health | 124.04M |
| Little Green Pharma | 38.49M |
| IDT Australia | 19.77M |
| ECS Botanics Holdings | 19.36M |
| Elixinol Wellness | 15.85M |
| Peak Processing | 15.49M |
| Cann Group | 13.25M |
| Epsilon Healthcare | 6.13M |